![]() |
市場調查報告書
商品編碼
1819863
微生物組定序服務市場報告(按技術(合成定序、連接定序、焦磷酸定序、桑格定序等)、研究類型、實驗室類型、應用、最終用戶和地區分類)2025 年至 2033 年Microbiome Sequencing Services Market Report by Technology (Sequencing by Synthesis, Sequencing by Ligation, Pyrosequencing, Sanger Sequencing, and Others), Research Type, Laboratory Type, Application, End User, and Region 2025-2033 |
2024年,全球微生物組定序服務市場規模達26.106億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到112.605億美元,2025-2033年期間的複合年成長率(CAGR)為16.75%。人群中傳染病發病率的上升、對包括FMT在內的基於微生物組的療法的偏好日益成長,以及微生物組測序在獸醫學中的應用日益廣泛,是推動市場發展的主要因素。
微生物組定序服務涉及對棲息於各種環境(包括人體)中的微生物群落進行分析。這些服務是專門設計用於識別和分析特定生態系統(例如人體腸道、土壤或水體)中各種微生物的程序。它們使用先進的脫氧核糖核酸 (DNA) 定序技術來解碼微生物的遺傳物質,從而使研究人員和醫療保健專業人員能夠了解這些微生物群落的組成、多樣性和功能。
人群中傳染病發病率的不斷上升,催生了對用於研究宿主-病原體關係的微生物組測序服務的需求,導致全球對該服務的需求不斷成長。此外,人們越來越傾向於基於微生物組的治療方法,包括糞便微生物移植 (FMT),這需要準確的微生物組分析,以確保治療的有效性和安全性,這有利於市場的成長。除此之外,獸醫學擴大採用微生物組定序來了解動物健康、預防疾病和提高畜牧業產量,這對市場產生了積極的影響。此外,製藥業的擴張正在推動微生物組資料在新藥開發中的應用,特別是針對胃腸道疾病的藥物,這有助於市場的成長。此外,依賴數據驅動決策的精準農業實踐的日益普及,正在促進市場的成長。
個人化醫療和療法的增加
隨著個人化醫療的興起,對微生物組定序服務的需求也日益成長,以便為個別患者提供個人化的治療和介入方案。推動微生物組定序服務需求成長的因素之一是,人們認知到每個人的微生物組都是獨一無二的,並且會顯著影響他們對治療的反應。無論是最佳化益生菌方案、指導飲食建議,或是預測藥物療效,微生物組資料都不可或缺。患者和醫療保健提供者擴大尋求這些洞察,以獲得更好的治療效果、最大限度地減少副作用並增強整體健康。因此,隨著個人化醫療成為現代醫療保健的核心原則,對微生物組定序服務的需求也不斷成長。
消費者意識和健康意識的提高
消費者對微生物組在健康保健中作用的認知正在穩步提升。人們越來越積極主動地關注自身健康,尋求最佳化微生物組以改善健康狀況的方法。這一趨勢源自於直接面對消費者的微生物組檢測試劑盒的出現,這些試劑盒能夠幫助個人深入了解腸道菌叢。隨著消費者對微生物組與各種健康問題之間聯繫的理解加深,他們開始尋求微生物組定序服務進行深入分析並獲得個人化建議。公眾興趣的激增推動了對微生物組測序服務的需求,因為人們希望透過明智的生活方式選擇和飲食調整來促進更健康的微生物組。
日益成長的監管要求和品質保證
醫療保健、農業和食品安全領域的監管機構越來越認知到微生物組資料在確保安全和品質標準方面的重要性。例如,在食品行業,微生物組測序用於透過識別潛在病原體或腐敗菌來監測和改善食品安全。同樣,農業監管機構可能要求進行微生物組評估,以確保永續的農業實踐。遵守這些法規需要利用微生物組定序服務來維持高品質標準,因此,致力於滿足監管要求並確保產品安全的企業和組織對此的需求持續存在。
The global microbiome sequencing services market size reached USD 2,610.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 11,260.5 Million by 2033, exhibiting a growth rate (CAGR) of 16.75% during 2025-2033. The increasing incidences of infectious diseases among the masses, rising inclination towards microbiome-based therapeutics, including FMT, and the growing adoption of microbiome sequencing in veterinary medicine are some of the major factors propelling the market.
Microbiome sequencing services involve the analysis of microbial communities that inhabit various environments, including the human body. They are specialized procedures designed to identify and analyze the diverse microorganisms living in a particular ecosystem, such as the human gut, soil, or water. They use advanced deoxyribonucleic acid (DNA) sequencing technologies to decode the genetic material of microorganisms, which allows researchers and healthcare professionals to understand the composition, diversity, and function of these microbial communities.
Increasing incidences of infectious diseases among the masses are catalyzing the demand for microbiome sequencing services for studying host-pathogen relationships, which lead to rising demand for its services around the world. Moreover, the rising inclination towards microbiome-based therapeutics, including fecal microbiota transplantation (FMT), that necessitates accurate microbiome profiling to ensure treatment efficacy and safety is favoring the growth of the market. Apart from this, the growing adoption of microbiome sequencing in veterinary medicine for understanding animal health, disease prevention, and improving livestock production is influencing the market positively. In addition, the expansion of the pharmaceutical industry is driving the use of microbiome data to develop novel drugs, particularly those targeting gastrointestinal diseases, which is contributing to the market growth. Furthermore, the increasing adoption of precision agriculture practices, which rely on data-driven decision-making, is bolstering the market growth.
Increase in personalized medicine and therapies
With the rising use of personalized medicine, there is a rise in the demand for microbiome sequencing services to offer tailoring treatments and interventions to individual patients. One of the driving forces behind the demand for microbiome sequencing services is the recognition that each microbiome of a person is unique and can significantly impact their response to treatments. Whether it is optimizing probiotic regimens, guiding dietary recommendations, or predicting drug efficacy, microbiome data is indispensable. Patients and healthcare providers increasingly seek these insights to achieve better treatment outcomes, minimize adverse effects, and enhance overall wellness. Consequently, the demand for microbiome sequencing services is rising as personalized medicine is becoming a central tenet of modern healthcare.
Rise in consumer awareness and wellness
Consumer awareness about the role of microbiomes in health and wellness has been steadily increasing. People are becoming more proactive about their health, seeking ways to optimize their microbiomes for improved well-being. This trend is driven by the availability of direct-to-consumer microbiome testing kits that provide individuals with insights into their gut microbiota. As consumers gain a better understanding of the connections between their microbiome and various health aspects, they are turning to microbiome sequencing services for in-depth analysis and personalized recommendations. This surge in interest from the public is propelling the demand for microbiome sequencing services, as individuals seek to make informed lifestyle choices and dietary adjustments to promote a healthier microbiome.
Growing regulatory requirements and quality assurance
Regulatory bodies in healthcare, agriculture, and food safety are increasingly recognizing the importance of microbiome data in ensuring safety and quality standards. For instance, in the food industry, microbiome sequencing is used to monitor and improve food safety by identifying potential pathogens or spoilage organisms. Similarly, regulatory agencies in agriculture may require microbiome assessments to ensure sustainable farming practices. Compliance with these regulations necessitates the utilization of microbiome sequencing services to maintain high-quality standards, leading to a consistent demand from businesses and organizations striving to meet regulatory requirements and ensure the safety of their products.
Sequencing by synthesis (SBS) dominates the market
Outsourced research holds the largest share in the market
Wet labs hold the largest share in the market
Shotgun sequencing holds the largest share in the market
Pharmaceutical and biotechnology companies dominate the market
The leading companies are adopting the use of high throughput sequencing in microbiome sequencing services to enable the simultaneous analysis of numerous microbial samples, which facilitates large-scale studies and delivers high-resolution data on microbial community composition. They are also using metagenomics that allows researchers to sequence the DNA of an entire microbial community in a sample without isolating individual species and enables a holistic view of the microbiome. Moreover, key players are integrating artificial intelligence (AI) and machine learning (ML) into microbiome data analysis that help identify patterns, predict microbial interactions, and discover biomarkers associated with health or disease, which enhances the interpretability of complex microbiome datasets.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: